404 related articles for article (PubMed ID: 16546222)
21. [Perioperative detection of MAGE-1mRNA and AFP mRNA in peripheral blood of patients with hepatocellular carcinoma: relationships with recurrence].
Yang SZ; Dong JH; Zhu J; Li K; Zhang Y
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(9):595-8. PubMed ID: 15949354
[TBL] [Abstract][Full Text] [Related]
22. [Expression and clinical significance of MAGE-4 gene in human hepatocellular carcinoma].
Zhao H; Rui J; Cong X; Zhao Y; Wang S; Chen S; Wang Y; Wang Y; Leng X; Chen W
Zhonghua Gan Zang Bing Za Zhi; 2002 Apr; 10(2):100-2. PubMed ID: 11983123
[TBL] [Abstract][Full Text] [Related]
23. Expression of the MAGE-1 gene in human hepatocellular carcinomas.
Chen H; Cai S; Wang Y; Zhao H; Peng J; Pang X; Zhu J; Cong X; Rui J; Leng X; Du R; Wang Y; Vaughan H; Cebon J; Burgess AW; Chen W
Chin Med J (Engl); 2000 Dec; 113(12):1112-8. PubMed ID: 11776148
[TBL] [Abstract][Full Text] [Related]
24. Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma.
Ikeguchi M; Hirooka Y; Kaibara N
Cancer; 2002 Nov; 95(9):1938-45. PubMed ID: 12404288
[TBL] [Abstract][Full Text] [Related]
25. Cloning and expression of a developmentally regulated transcript MXR7 in hepatocellular carcinoma: biological significance and temporospatial distribution.
Hsu HC; Cheng W; Lai PL
Cancer Res; 1997 Nov; 57(22):5179-84. PubMed ID: 9371521
[TBL] [Abstract][Full Text] [Related]
26. Expression of multiple cancer-testis antigen genes in gastrointestinal and breast carcinomas.
Mashino K; Sadanaga N; Tanaka F; Yamaguchi H; Nagashima H; Inoue H; Sugimachi K; Mori M
Br J Cancer; 2001 Sep; 85(5):713-20. PubMed ID: 11531257
[TBL] [Abstract][Full Text] [Related]
27. [Overexpression and genomic amplification of decoy receptor 3 in hepatocellular carcinoma and significance thereof].
Shen HW; Wu YL; Peng SY
Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):744-7. PubMed ID: 12899749
[TBL] [Abstract][Full Text] [Related]
28. Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma.
Wu W; Yao DF; Yuan YM; Fan JW; Lu XF; Li XH; Qiu LW; Zong L; Wu XH
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):538-44. PubMed ID: 17085339
[TBL] [Abstract][Full Text] [Related]
29. Detecting AFP mRNA in peripheral blood of the patients with hepatocellular carcinoma, liver cirrhosis and hepatitis.
Yao F; Guo JM; Xu CF; Lou YL; Xiao BX; Zhou WH; Chen J; Hu YR; Liu Z; Hong GF
Clin Chim Acta; 2005 Nov; 361(1-2):119-27. PubMed ID: 15993394
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic value of cancer-testis antigen mRNA in peripheral blood from hepatocellular carcinoma patients.
Zhao L; Mou DC; Peng JR; Huang L; Wu ZA; Leng XS
World J Gastroenterol; 2010 Aug; 16(32):4072-8. PubMed ID: 20731022
[TBL] [Abstract][Full Text] [Related]
31. [Detection of tumor cells in peripheral blood of patients with gastric cancer using mRNA of MAGE genes as markers].
Wang WX; Li YB; Xie XL; Shu XL; Ouyang XH
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Nov; 12(6):611-4. PubMed ID: 19921576
[TBL] [Abstract][Full Text] [Related]
32. Serum human telomerase reverse transcriptase messenger RNA as a novel tumor marker for hepatocellular carcinoma.
Miura N; Maeda Y; Kanbe T; Yazama H; Takeda Y; Sato R; Tsukamoto T; Sato E; Marumoto A; Harada T; Sano A; Kishimoto Y; Hirooka Y; Murawaki Y; Hasegawa J; Shiota G
Clin Cancer Res; 2005 May; 11(9):3205-9. PubMed ID: 15867214
[TBL] [Abstract][Full Text] [Related]
33. [Correlation of NY-ESO-1 gene and protein expression to metastasis and clinicopathologic features of hepatocellular carcinoma].
Zhang WM; Xiao G; Xie D; Zhang M; Guo AL; Wen JM
Ai Zheng; 2005 May; 24(5):622-6. PubMed ID: 15890110
[TBL] [Abstract][Full Text] [Related]
34. [Expression and implication of multidrug resistance associated -protein gene in primary hepatocellular carcinoma].
Wang BL; Chen XP; Zhai SP
Zhonghua Gan Zang Bing Za Zhi; 2003 Oct; 11(10):609-11. PubMed ID: 14572339
[TBL] [Abstract][Full Text] [Related]
35. Hematogenous spreading of hepatocellular carcinoma cells: possible participation in recurrence in the liver.
Funaki NO; Tanaka J; Seto SI; Kasamatsu T; Kaido T; Imamura M
Hepatology; 1997 Mar; 25(3):564-8. PubMed ID: 9049199
[TBL] [Abstract][Full Text] [Related]
36. Identification of novel aberrant methylation of BASP1 and SRD5A2 for early diagnosis of hepatocellular carcinoma by genome-wide search.
Moribe T; Iizuka N; Miura T; Stark M; Tamatsukuri S; Ishitsuka H; Hamamoto Y; Sakamoto K; Tamesa T; Oka M
Int J Oncol; 2008 Nov; 33(5):949-58. PubMed ID: 18949357
[TBL] [Abstract][Full Text] [Related]
37. Loss of expression of Kruppel-like factor 6 in primary hepatocellular carcinoma and hepatoma cell lines.
Wang SP; Zhou HJ; Chen XP; Ren GY; Ruan XX; Zhang Y; Zhang RL; Chen J
J Exp Clin Cancer Res; 2007 Mar; 26(1):117-24. PubMed ID: 17550140
[TBL] [Abstract][Full Text] [Related]
38. [Expression of NET-1 gene and protein in hepatocellular carcinoma and related tissues].
Chen L; Shen AG; Wang GL; Lu P; Li XY
Ai Zheng; 2006 Mar; 25(3):320-5. PubMed ID: 16536986
[TBL] [Abstract][Full Text] [Related]
39. Expression of cancer-testis antigen (CTA) genes in intrahepatic cholangiocarcinoma.
Utsunomiya T; Inoue H; Tanaka F; Yamaguchi H; Ohta M; Okamoto M; Mimori K; Mori M
Ann Surg Oncol; 2004 Oct; 11(10):934-40. PubMed ID: 15466353
[TBL] [Abstract][Full Text] [Related]
40. Alterations of the fragile histidine triad gene in hepatitis C virus-associated hepatocellular carcinoma.
Zekri AR; Bahnassy AA; Hafez M; El-Shehaby AM; Sherif GM; Khaled HM; Zakhary N
J Gastroenterol Hepatol; 2005 Jan; 20(1):87-94. PubMed ID: 15610452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
